Bendamustine/Brentuximab Vedotin Regimen

Preferred Label : Bendamustine/Brentuximab Vedotin Regimen;

NCIt synonyms : Bendeka/Adcetris; Brentuximab Vedotin-Bendamustine; Brentuximab Vedotin/Bendamustine; Brentuximab Vedotin/Bendamustine Regimen; Bendamustine/Brentuximab Vedotin; Bendamustine-Brentuximab Vedotin; Bendamustine/Adcetris; Adcetris/Bendamustine;

NCIt related terms : Bendamustine and Brentuximab vedotin;

NCIt definition : A regimen consisting of bendamustine and brentuximab vedotin that can be used for the treatment of Hodgkin lymphoma (HL), T-cell lymphomas, and mycosis fungoides/Sezary syndrome.;

NCI Metathesaurus CUI : CL969525;

Codes from synonyms : 46322;

Détails

Origin ID

C160524;

UMLS CUI

C5205328;

Semantic type(s)
- Therapeutic or Preventive Procedure [UMLS semantic type]
chemotherapy_regimen_has_component
- Bendamustine Hydrochloride [NCIt concept]
- Brentuximab Vedotin [NCIt concept]
concept_is_in_subset
- HemOnc Regimen Terminology [NCIt concept]
- Multi-agent Therapeutic Regimens [NCIt concept]
- Pharmacotherapy Regimens [NCIt concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients